<DOC>
	<DOC>NCT01964989</DOC>
	<brief_summary>Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children ≥6 to &lt;72 Months of Age.</brief_summary>
	<brief_title>Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Children, males and females, healthy or at high risk of complications from influenza, between ≥6 months to &lt;72 months of age Documented consent provided by the subject's parent(s)/legal guardian(s) Subjects and/or subject's parent(s)/legal guardian(s) able to comply with all study procedures. Children with history of allergy to vaccine components. Additional eligibility criteria may be discussed by contacting the site</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>72 Months</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>children</keyword>
</DOC>